Sep 15, 2025

When Guardrails Fail: Dual-Use Misuse of AI in Retrosynthesis Through Iterative Refinement–Induced Self-Jailbreaking

Andrei Avram, Chido Chikomo, Hanadi Al-Samarrai, Tiwai Mhundwa,Wydad El Azzaoui Alaoui Belghiti, Isabel Barberá

Artificial intelligence (AI) is transforming drug discovery, with large language models (LLMs) enabling rapid retrosynthesis planning. Yet these advances also pose dual-use risks, as adversarial prompting can redirect models toward generating harmful pathways. We evaluate Iterative Refinement Induced Self-Jailbreaking (IRIS), showing that while newer models resist more robustly, systems like GPT-4 can be induced to produce stepwise synthesis guidance. This underscores the fragility of guardrails and the urgency of continuous red-teaming. We argue that AI systems in drug discovery should be classified as high-risk under the EU AI Act and propose a severity-based governance framework to proportionately manage jailbreaks while safeguarding biomedical innovation.

Reviewer's Comments

Reviewer's Comments

Arrow
Arrow
Arrow

This project does a solid job of showing how dynamic jailbreaks might work and is commendably transparent about its limitations. The scope is fairly narrow, though, and the specific jailbreak technique explored doesn’t hold up against more recent models.

On the dual-use side, it’s good that the risks are considered, but simply hiding prompts and outputs doesn’t feel like a meaningful safeguard, since the results were easy to replicate. That suggests either the full prompts aren’t truly infohazardous (which seems likely), or stronger safeguards are needed.

The project would benefit from involving domain experts to assess how dangerous the outputs really are and comparing them with what’s already available online. A useful next step would be to engage policy-adjacent experts to identify what kind of evidence in this vein could realistically influence regulation, and to push further in that direction. It would also be valuable to experiment with attack methods that are more effective against state-of-the-art models.

Specify which Gemini model was used (2.5 flash, pro, etc.)

Go into more detail about how a model developer would operationalize the severity based classification framework and evidence that something like this isn't already being employed by OpenAI, GDM, etc.

In the results section, it's unclear how dangerous of a retrosynthesis task you prompted the model with. It may be the case that something actually harmful would be harder to jailbreak vs a more benign task. I would have liked to see 4-5 variants of the task to see if ASR varies, which could shed light on my previous question.

Overall a well framed project that is relevant to the CBRN threat model, but needs a little more depth of experimentation and analysis. Hard to reproduce, no code available or copy+pastable prompts (even if redacted for infohazards).

This project does a strong job of demonstrating Iterative Refinement Induced Self-Jailbreaking (IRIS) in a biosecurity-relevant context, and I especially appreciated the clear, step-by-step example. The recommendations to classify AI in drug discovery as “high-risk” under the EU AI Act and to treat jailbreaks differently according to severity are also sensible.

That said, some aspects could be clarified. The proposed severity-based framework is an interesting idea, but it’s unclear how it would work in practice, since prompts themselves are difficult to regulate. In addition, the paper demonstrates jailbreaks on general-purpose models (ChatGPT, Gemini) but makes recommendations for models used in drug discovery. It would help to clarify whether narrow drug discovery models can also be jailbroken, and whether general-purpose models should themselves be considered within the “drug discovery AI” category. The project would also benefit from a stronger link between the proposed recommendations and actual risk reduction: how would these governance measures mitigate jailbreaks in practice?

Finally, it’s interesting that GPT-4 could be jailbroken but GPT-5 resisted. For future work it would be useful to test whether newer models consistently show greater resilience. If that trend holds, jailbreaks may become a less significant concern over time.

Cite this work

@misc {

title={

(HckPrj) When Guardrails Fail: Dual-Use Misuse of AI in Retrosynthesis Through Iterative Refinement–Induced Self-Jailbreaking

},

author={

Andrei Avram, Chido Chikomo, Hanadi Al-Samarrai, Tiwai Mhundwa,Wydad El Azzaoui Alaoui Belghiti, Isabel Barberá

},

date={

9/15/25

},

organization={Apart Research},

note={Research submission to the research sprint hosted by Apart.},

howpublished={https://apartresearch.com}

}

Recent Projects

Apr 27, 2026

OliGraph: graph-based screening of large oligopools

Existing synthesis screening tools cannot evaluate short oligonucleotide pools, whose overlapping fragments can be reassembled into regulated sequences via polymerase cycling assembly (PCA) yet fall below gene-length detection thresholds. We present OliGraph, an open-source tool that constructs a bi-directed overlap graph from an oligonucleotide pool and extracts contigs for downstream gene-length screening. An optional PCA mode retains only cross-strand overlaps consistent with PCA chemistry. We validated OliGraph in a blinded study across ten simulated pools (70–9,184 oligonucleotides, 30–300 bp) spanning four risk categories. BLAST screening of individual oligonucleotides failed to identify sequences of concern in most pools: three returned zero hits, and vector noise obscured true positives in the remainder. After OliGraph assembly, contig-level BLAST matched the longest assembled sequences (up to 1,905 bp) to sequences of concern at 97–100% identity. In one pool, assembly collapsed 1,634 individual BLAST results into 10 hits from a single contig, all assigned to the same source organism. PCA mode correctly distinguished assemblable from non-assemblable fragments within the same pool. Two pools with no assemblable structure yielded no contigs. OliGraph processed all pools in under 0.2 seconds, fast enough for real-time order screening and consistent with proposals to bring oligonucleotide orders within the scope of synthesis screening regulation.

Read More

Apr 27, 2026

BioRT-Bench: A Multi-Attack Red-Teaming Benchmark for Bio-Misuse Safeguards in Frontier LLMs

Frontier AI laboratories are expected to maintain safeguards against biological misuse, but whether deployed models actually refuse bio-misuse queries under adversarial pressure is largely unmeasured in the public literature. We introduce BioRT-Bench, a benchmark that runs four attack methods (direct request, PAIR, Crescendo, and base64 encoding) against four frontier models (Claude Sonnet 4.6, GPT-5.4, DeepSeek V4-flash, Kimi K2.5) across 40 prompts spanning five biosecurity-relevant categories. Responses are scored by a calibrated judge extending StrongREJECT with two bio-specific dimensions: specificity and actionability. We measure Attack Success Rate (ASR), where 0 means the model fully refused and 1 means it provided specific, actionable bio-misuse content. Our results reveal a sharp robustness divide: Chinese frontier models (DeepSeek, Kimi) have under 5% refusal rates even under direct request (ASR 0.88 and 0.79), while Western models (Claude, GPT) maintain substantially stronger safeguards (ASR 0.15 and 0.16). Crescendo is the most effective attack across all models, both in bypassing refusal and in eliciting actionable content. Claude Sonnet 4.6 is the most robust model tested, achieving 100% refusal against base64-encoded prompts.

Read More

Apr 27, 2026

PROTEUS (PROTein Evaluation for Unusual Sequences): Structure-Informed Safety Screening for de novo and Evasion-Prone Protein-Coding Sequences

AI protein design tools like RFdiffusion, ProteinMPNN, and Bindcraft make it trivial to produce low-homology sequences that fold into active, potentially hazardous architectures. However, sequence homology-based biosafety screening tools cannot detect proteins that pose functional risk through structurally novel mechanisms with no sequence precedent. We present a tiered computational pipeline that addresses this gap by combining MMseqs2 sequence alignment with structure-based comparison via FoldSeek and DALI against curated toxin databases totaling ~34,000 entries. AlphaFold2-predicted structures are screened for both global fold similarity (FoldSeek) and local active/allosteric site geometry (DALI), capturing convergent functional hazards that sequence screening misses. The pipeline was validated against a panel of toxins, benign proteins, structural mimics, and de novo-designed Munc13 binders, as well as modified ricin variants with residue substitutions. We additionally tested robustness to partial-synthesis evasion, where a bad actor submits multiple shorter coding sequences intended for downstream reassembly into a full toxin-coding gene. We found that while sequence-based screening did not identify any de novo ricin analogues with high certainty, the combined pipeline with FoldSeek and DALI identified all 24 tested de novo ricins as toxic.

Read More

Apr 27, 2026

OliGraph: graph-based screening of large oligopools

Existing synthesis screening tools cannot evaluate short oligonucleotide pools, whose overlapping fragments can be reassembled into regulated sequences via polymerase cycling assembly (PCA) yet fall below gene-length detection thresholds. We present OliGraph, an open-source tool that constructs a bi-directed overlap graph from an oligonucleotide pool and extracts contigs for downstream gene-length screening. An optional PCA mode retains only cross-strand overlaps consistent with PCA chemistry. We validated OliGraph in a blinded study across ten simulated pools (70–9,184 oligonucleotides, 30–300 bp) spanning four risk categories. BLAST screening of individual oligonucleotides failed to identify sequences of concern in most pools: three returned zero hits, and vector noise obscured true positives in the remainder. After OliGraph assembly, contig-level BLAST matched the longest assembled sequences (up to 1,905 bp) to sequences of concern at 97–100% identity. In one pool, assembly collapsed 1,634 individual BLAST results into 10 hits from a single contig, all assigned to the same source organism. PCA mode correctly distinguished assemblable from non-assemblable fragments within the same pool. Two pools with no assemblable structure yielded no contigs. OliGraph processed all pools in under 0.2 seconds, fast enough for real-time order screening and consistent with proposals to bring oligonucleotide orders within the scope of synthesis screening regulation.

Read More

Apr 27, 2026

BioRT-Bench: A Multi-Attack Red-Teaming Benchmark for Bio-Misuse Safeguards in Frontier LLMs

Frontier AI laboratories are expected to maintain safeguards against biological misuse, but whether deployed models actually refuse bio-misuse queries under adversarial pressure is largely unmeasured in the public literature. We introduce BioRT-Bench, a benchmark that runs four attack methods (direct request, PAIR, Crescendo, and base64 encoding) against four frontier models (Claude Sonnet 4.6, GPT-5.4, DeepSeek V4-flash, Kimi K2.5) across 40 prompts spanning five biosecurity-relevant categories. Responses are scored by a calibrated judge extending StrongREJECT with two bio-specific dimensions: specificity and actionability. We measure Attack Success Rate (ASR), where 0 means the model fully refused and 1 means it provided specific, actionable bio-misuse content. Our results reveal a sharp robustness divide: Chinese frontier models (DeepSeek, Kimi) have under 5% refusal rates even under direct request (ASR 0.88 and 0.79), while Western models (Claude, GPT) maintain substantially stronger safeguards (ASR 0.15 and 0.16). Crescendo is the most effective attack across all models, both in bypassing refusal and in eliciting actionable content. Claude Sonnet 4.6 is the most robust model tested, achieving 100% refusal against base64-encoded prompts.

Read More

This work was done during one weekend by research workshop participants and does not represent the work of Apart Research.
This work was done during one weekend by research workshop participants and does not represent the work of Apart Research.